However, it is a well-known phenomenon that individuals can have germline mutations in more than one cancer susceptibility gene, including simultaneous BRCA1 and BRCA2 mutations34–36, and that either one may be an initiating factor in an individual’s cancer or the mutations in the HR pathway may act synergistically in tumor development. This evidence concerns the gene BRCA2 and neoplasm.